Kraig Biocraft Laboratories, Inc. KBLB

KBLB Company Overview

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development and commercialization of genetically engineered spider silk materials. The company operates at the intersection of advanced materials, biotechnology, and textile manufacturing, with a primary emphasis on producing recombinant spider silk fibers through genetically modified silkworms. Its core business objective is to create high-performance silk-based materials that combine the strength, elasticity, and lightweight properties associated with natural spider silk while enabling scalable commercial production. The company’s potential applications span technical textiles, defense materials, medical products, performance apparel, and industrial composites.

Kraig Biocraft Laboratories was founded in 2006 and is headquartered in Ann Arbor, Michigan. The company evolved from early-stage genetic engineering research into a vertically integrated biotechnology and silk production enterprise focused on commercial-scale deployment. Over time, KBLB has concentrated on developing proprietary silkworm strains designed to produce specialized silk variants, including fibers marketed under names such as Dragon Silk and Monster Silk. Public filings and company disclosures indicate that its strategy has increasingly emphasized production scaling, supply chain development, and international manufacturing partnerships, particularly in Southeast Asia.